메뉴 건너뛰기




Volumn 28, Issue 2, 2015, Pages 193-198

Antibiotic de-escalation in the ICU: How is it best done?

Author keywords

De escalation; Empirical therapy; Hospital acquired pneumonia; Sepsis; Survival

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

EID: 84926310332     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000141     Document Type: Review
Times cited : (44)

References (37)
  • 1
    • 0347122086 scopus 로고    scopus 로고
    • Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis
    • Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31:2742-2751.
    • (2003) Crit Care Med , vol.31 , pp. 2742-2751
    • Garnacho-Montero, J.1    Garcia-Garmendia, J.L.2    Barrero-Almodovar, A.3
  • 2
    • 0038555339 scopus 로고    scopus 로고
    • Community-acquired bloodstream infection in critically ill adult patients: Impact of shock and inappropriate antibiotic therapy on survival
    • Vallé s J, Rello J, Ochagavá A, et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123:1615-1624.
    • (2003) Chest , vol.123 , pp. 1615-1624
    • Vallé, S.J.1    Rello, J.2    Ochagavá, A.3
  • 3
    • 38349108756 scopus 로고    scopus 로고
    • Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: A matched cohort study
    • Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: A matched cohort study. J Antimicrob Chemother 2008; 61:436-441.
    • (2008) J Antimicrob Chemother , vol.61 , pp. 436-441
    • Garnacho-Montero, J.1    Ortiz-Leyba, C.2    Herrera-Melero, I.3
  • 4
    • 84869016925 scopus 로고    scopus 로고
    • Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality
    • Edusepsis Study Group
    • Dáz-Martń A, Martńez-Gonzá lezML, Ferrer R, et al., Edusepsis Study Group. Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality. Crit Care 2012; 16:R223.
    • (2012) Crit Care , vol.16 , pp. R223
    • Dáz-Martń, A.1    Martńez-Gonzá Lez, M.L.2    Ferrer, R.3
  • 5
    • 13644269309 scopus 로고    scopus 로고
    • Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare associated pneumonia
    • American Thoracic Society/Infectious Diseases Society of America
    • American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 388-416
  • 6
    • 84873339299 scopus 로고    scopus 로고
    • Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
    • Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med 2013; 41:580-637.
    • (2013) Crit Care Med , vol.41 , pp. 580-637
    • Dellinger, R.P.1    Levy, M.M.2    Rhodes, A.3
  • 7
    • 84889824250 scopus 로고    scopus 로고
    • European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia
    • ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN
    • Averbuch D, Orasch C, Cordonnier C, et al., ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013; 98:1826-1835.
    • (2013) Haematologica , vol.98 , pp. 1826-1835
    • Averbuch, D.1    Orasch, C.2    Cordonnier, C.3
  • 8
    • 78650166326 scopus 로고    scopus 로고
    • De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medicosurgical intensive care unit
    • Morel J, Casoetto J, Jospé R, et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medicosurgical intensive care unit. Crit Care 2010; 14:R225.
    • (2010) Crit Care , vol.14 , pp. R225
    • Morel, J.1    Casoetto, J.2    Jospé, R.3
  • 9
    • 84860226563 scopus 로고    scopus 로고
    • Antibiotic strategies in severe nosocomial sepsis: Why do we not deescalate more often?
    • Heenen S, Jacobs F, Vincent J-L. Antibiotic strategies in severe nosocomial sepsis: why do we not deescalate more often? Crit Care Med 2012; 40:1404-1409.
    • (2012) Crit Care Med , vol.40 , pp. 1404-1409
    • Heenen, S.1    Jacobs, F.2    Vincent, J.-L.3
  • 10
    • 84905972598 scopus 로고    scopus 로고
    • Development of an antibiotic spectrum score based on Veterans Affairs culture and susceptibility data for the purpose of measuring antibiotic de-escalation: A modified Delphi approach
    • Madaras-Kelly K, Jones M, Remington R, et al. Development of an antibiotic spectrum score based on Veterans Affairs culture and susceptibility data for the purpose of measuring antibiotic de-escalation: A modified Delphi approach. Infect Control Hosp Epidemiol 2014; 35:1103-1113.
    • (2014) Infect Control Hosp Epidemiol , vol.35 , pp. 1103-1113
    • Madaras-Kelly, K.1    Jones, M.2    Remington, R.3
  • 11
    • 78049522796 scopus 로고    scopus 로고
    • Long-term impacts of antibiotic exposure on the human intestinal microbiota
    • Jernberg C, Lö fmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156:3216-3223.
    • (2010) Microbiology , vol.156 , pp. 3216-3223
    • Jernberg, C.1    Lö Fmark, S.2    Edlund, C.3    Jansson, J.K.4
  • 12
    • 84891026537 scopus 로고    scopus 로고
    • Deescalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock
    • Garnacho-Montero J, Gutié rrez-Pizarraya A, Escoresca-Ortega A, et al. Deescalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med 2014; 40:32-40.
    • (2014) Intensive Care Med , vol.40 , pp. 32-40
    • Garnacho-Montero, J.1    Gutié Rrez-Pizarraya, A.2    Escoresca-Ortega, A.3
  • 13
    • 8544252455 scopus 로고    scopus 로고
    • De-escalation therapy in ventilatorassociated pneumonia
    • Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilatorassociated pneumonia. Crit Care Med 2004; 32:2183-2190.
    • (2004) Crit Care Med , vol.32 , pp. 2183-2190
    • Rello, J.1    Vidaur, L.2    Sandiumenge, A.3
  • 14
    • 67649639469 scopus 로고    scopus 로고
    • Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    • Eachempati SR, Hydo LJ, Shou J, Barie PS. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma 2009; 66:1343-1348.
    • (2009) J Trauma , vol.66 , pp. 1343-1348
    • Eachempati, S.R.1    Hydo, L.J.2    Shou, J.3    Barie, P.S.4
  • 15
    • 79952095005 scopus 로고    scopus 로고
    • Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia
    • Joung MK, Lee JA, Moon SY, et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care 2011; 15:R79.
    • (2011) Crit Care , vol.15 , pp. R79
    • Joung, M.K.1    Lee, J.A.2    Moon, S.Y.3
  • 16
    • 33646471520 scopus 로고    scopus 로고
    • Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia
    • Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006; 129:1210-1218.
    • (2006) Chest , vol.129 , pp. 1210-1218
    • Kollef, M.H.1    Morrow, L.E.2    Niederman, M.S.3
  • 17
    • 34548164363 scopus 로고    scopus 로고
    • De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate
    • Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 2007; 33:1533-1540.
    • (2007) Intensive Care Med , vol.33 , pp. 1533-1540
    • Giantsou, E.1    Liratzopoulos, N.2    Efraimidou, E.3
  • 18
    • 34247551035 scopus 로고    scopus 로고
    • Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study
    • ADANN Study Group
    • Alvarez-Lerma F, Alvarez B, Luque P, et al., ADANN Study Group. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study. Crit Care 2006; 10:R78.
    • (2006) Crit Care , vol.10 , pp. R78
    • Alvarez-Lerma, F.1    Alvarez, B.2    Luque, P.3
  • 19
    • 84901602158 scopus 로고    scopus 로고
    • Bloodstreaminfectionsandsepsis inGreece: Over-time changeofepidemiology and impact of de-escalation on final outcome
    • Hellenic Sepsis Study Group
    • Koupetori M, Retsas T, Antonakos N, et al., Hellenic Sepsis Study Group. Bloodstreaminfectionsandsepsis inGreece: over-time changeofepidemiology and impact of de-escalation on final outcome. BMC Infect Dis 2014; 14:272.
    • (2014) BMC Infect Dis , vol.14 , pp. 272
    • Koupetori, M.1    Retsas, T.2    Antonakos, N.3
  • 20
    • 84891001182 scopus 로고    scopus 로고
    • De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: Results from an observational study
    • Mokart D, Slehofer G, Lambert J, et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: Results from an observational study. Intensive Care Med 2014; 40:41-49.
    • (2014) Intensive Care Med , vol.40 , pp. 41-49
    • Mokart, D.1    Slehofer, G.2    Lambert, J.3
  • 21
    • 84862812810 scopus 로고    scopus 로고
    • Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: A randomized clinical trial
    • Kim JW, Chung J, Choi SH, et al. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: A randomized clinical trial. Crit Care 2012; 16:R28.
    • (2012) Crit Care , vol.16 , pp. R28
    • Kim, J.W.1    Chung, J.2    Choi, S.H.3
  • 22
    • 84919392230 scopus 로고    scopus 로고
    • Deescalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial
    • AZUREA Network Investigators
    • Leone M, Bechis C, Baumstarck K, et al., AZUREA Network Investigators. Deescalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial. Intensive Care Med 2014; 40:1399-1408.
    • (2014) Intensive Care Med , vol.40 , pp. 1399-1408
    • Leone, M.1    Bechis, C.2    Baumstarck, K.3
  • 23
    • 84880022981 scopus 로고    scopus 로고
    • Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients
    • Gonzalez L, Cravoisy A, Barraud D, et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Crit Care 2013; 17:R140.
    • (2013) Crit Care , vol.17 , pp. R140
    • Gonzalez, L.1    Cravoisy, A.2    Barraud, D.3
  • 24
    • 0033504530 scopus 로고    scopus 로고
    • Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillinresistant and methicillin-susceptible organisms
    • Gonzá lez C, Rubio M, Romero-Vivas J, et al. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillinresistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29:1171-1177.
    • (1999) Clin Infect Dis , vol.29 , pp. 1171-1177
    • Gonzá Lez, C.1    Rubio, M.2    Romero-Vivas, J.3
  • 25
    • 79955673698 scopus 로고    scopus 로고
    • Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
    • Paul M, Zemer-Wassercug N, Talker O, et al. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 2011; 17:1581-1586.
    • (2011) Clin Microbiol Infect , vol.17 , pp. 1581-1586
    • Paul, M.1    Zemer-Wassercug, N.2    Talker, O.3
  • 26
    • 84904564775 scopus 로고    scopus 로고
    • Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia
    • Foo H, Chater M, Maley M, van Hal SJ. Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia. J Antimicrob Chemother 2014; 69:2252-2257.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 2252-2257
    • Foo, H.1    Chater, M.2    Maley, M.3    Van Hal, S.J.4
  • 27
    • 4043059435 scopus 로고    scopus 로고
    • Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
    • Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004; 4:519-527.
    • (2004) Lancet Infect Dis , vol.4 , pp. 519-527
    • Safdar, N.1    Handelsman, J.2    Maki, D.G.3
  • 28
    • 34547700428 scopus 로고    scopus 로고
    • Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy
    • Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007; 35:1888-1895.
    • (2007) Crit Care Med , vol.35 , pp. 1888-1895
    • Garnacho-Montero, J.1    Sa-Borges, M.2    Sole-Violan, J.3
  • 29
    • 84879413256 scopus 로고    scopus 로고
    • Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: A post hoc analysis of a prospective cohort
    • Spanish Network for Research in Infectious Diseases (REIPI)
    • Peñ a C, Suarez C, Ocampo-Sosa A, et al., Spanish Network for Research in Infectious Diseases (REIPI). Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: A post hoc analysis of a prospective cohort. Clin Infect Dis 2013; 57:208-216.
    • (2013) Clin Infect Dis , vol.57 , pp. 208-216
    • Peñ, A.C.1    Suarez, C.2    Ocampo-Sosa, A.3
  • 30
    • 84910013793 scopus 로고    scopus 로고
    • Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort
    • GEIH/REIPIAb2010 Group
    • Ló pez-Corté s LE, Cisneros JM, Fernández-Cuenca F, et al., GEIH/REIPIAb2010 Group. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort. J Antimicrob Chemother 2014; 69:3119-3126.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 3119-3126
    • Ló Pez-Corté, S.L.E.1    Cisneros, J.M.2    Fernández-Cuenca, F.3
  • 31
    • 84866072596 scopus 로고    scopus 로고
    • Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae: Importance of combination therapy
    • Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55:943-950.
    • (2012) Clin Infect Dis , vol.55 , pp. 943-950
    • Tumbarello, M.1    Viale, P.2    Viscoli, C.3
  • 32
    • 82955233374 scopus 로고    scopus 로고
    • Imipenem: A potent inducer of multidrug resistance in Acinetobacter baumannii
    • Kuo HY, Chang KC, Kuo JW, et al. Imipenem: A potent inducer of multidrug resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2012; 39:33-38.
    • (2012) Int J Antimicrob Agents , vol.39 , pp. 33-38
    • Kuo, H.Y.1    Chang, K.C.2    Kuo, J.W.3
  • 33
    • 78649451111 scopus 로고    scopus 로고
    • De-escalation after empirical meropenem treatment in the intensive care unit: Fiction or reality?
    • De Waele JJ, Ravyts M, Depuydt P, et al. De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care 2010; 25:641-646.
    • (2010) J Crit Care , vol.25 , pp. 641-646
    • De Waele, J.J.1    Ravyts, M.2    Depuydt, P.3
  • 34
    • 71249146783 scopus 로고    scopus 로고
    • Introduction of ertapenem into a hospital formulary: Effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa
    • Goldstein EJ, Citron DM, Peraino V, et al. Introduction of ertapenem into a hospital formulary: Effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53:5122.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 5122
    • Goldstein, E.J.1    Citron, D.M.2    Peraino, V.3
  • 35
    • 84867709158 scopus 로고    scopus 로고
    • ESCMID- guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients
    • ESCMID Fungal Infection Study Group
    • Cornely OA, Bassetti M, Calandra T, et al., ESCMID Fungal Infection Study Group. ESCMID- guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18 (Suppl 7):19-37.
    • (2012) Clin Microbiol Infect , vol.18 , pp. 19-37
    • Cornely, O.A.1    Bassetti, M.2    Calandra, T.3
  • 36
    • 77957662332 scopus 로고    scopus 로고
    • Practice patterns for antibiotic deescalation in culture-negative healthcare-associated pneumonia
    • Schlueter M, James C, Dominguez A, et al. Practice patterns for antibiotic deescalation in culture-negative healthcare-associated pneumonia. Infection 2010; 38:357-362.
    • (2010) Infection , vol.38 , pp. 357-362
    • Schlueter, M.1    James, C.2    Dominguez, A.3
  • 37
    • 84874095242 scopus 로고    scopus 로고
    • A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia
    • Boyce JM, Pop OF, Abreu-Lanfranco O, et al. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia. Antimicrob Agents Chemother 2013; 57:1163-1168.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 1163-1168
    • Boyce, J.M.1    Pop, O.F.2    Abreu-Lanfranco, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.